ARTICLE | Clinical News
Transgene starts VIN3 Phase II
December 18, 2001 8:00 AM UTC
Transgene (NM:Transgene; TRGNY) started in France a placebo-controlled Phase II trial of its MVA-HPV-IL2 immunotherapeutic vaccine to treat vulvar intra-epithelial neoplasia (VIN3) in 30 female patien...